Literature DB >> 24510595

Protein knockouts in living eukaryotes using deGradFP and green fluorescent protein fusion targets.

Emmanuel Caussinus1, Oguz Kanca1, Markus Affolter1.   

Abstract

This unit describes deGradFP (degrade Green Fluorescent Protein), an easy-to-implement protein knockout method applicable in any eukaryotic genetic system. Depleting a protein in order to study its function in a living organism is usually achieved at the gene level (genetic mutations) or at the RNA level (RNA interference and morpholinos). However, any system that acts upstream of the proteic level depends on the turnover rate of the existing target protein, which can be extremely slow. In contrast, deGradFP is a fast method that directly depletes GFP fusion proteins. In particular, deGradFP is able to counteract maternal effects in embryos and causes early and fast onset loss-of-function phenotypes of maternally contributed proteins.
Copyright © 2013 John Wiley & Sons, Inc.

Keywords:  Drosophila; F-Box; GFP; nanobodies

Mesh:

Substances:

Year:  2013        PMID: 24510595     DOI: 10.1002/0471140864.ps3002s73

Source DB:  PubMed          Journal:  Curr Protoc Protein Sci        ISSN: 1934-3655


  10 in total

1.  Neuronal delivery of antibodies has therapeutic effects in animal models of botulism.

Authors:  Patrick M McNutt; Edwin J Vazquez-Cintron; Luis Tenezaca; Celinia A Ondeck; Kyle E Kelly; Mark Mangkhalakhili; James B Machamer; Christopher A Angeles; Elliot J Glotfelty; Jaclyn Cika; Cesar H Benjumea; Justin T Whitfield; Philip A Band; Charles B Shoemaker; Konstantin Ichtchenko
Journal:  Sci Transl Med       Date:  2021-01-06       Impact factor: 17.956

Review 2.  Finding their way: themes in germ cell migration.

Authors:  Lacy J Barton; Michelle G LeBlanc; Ruth Lehmann
Journal:  Curr Opin Cell Biol       Date:  2016-07-30       Impact factor: 8.382

3.  Protein interference applications in cellular and developmental biology using DARPins that recognize GFP and mCherry.

Authors:  Michael Brauchle; Simon Hansen; Emmanuel Caussinus; Anna Lenard; Amanda Ochoa-Espinosa; Oliver Scholz; Simon G Sprecher; Andreas Plückthun; Markus Affolter
Journal:  Biol Open       Date:  2014-11-21       Impact factor: 2.422

Review 4.  Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications.

Authors:  Yongzhong Wang; Zhen Fan; Lei Shao; Xiaowei Kong; Xianjuan Hou; Dongrui Tian; Ying Sun; Yazhong Xiao; Li Yu
Journal:  Int J Nanomedicine       Date:  2016-07-21

Review 5.  Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.

Authors:  Congcong Zhang; Rina M Ötjengerdes; Julian Roewe; Rebeca Mejias; Andrea L J Marschall
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807

Review 6.  Using Drosophila to study mechanisms of hereditary hearing loss.

Authors:  Tongchao Li; Hugo J Bellen; Andrew K Groves
Journal:  Dis Model Mech       Date:  2018-05-31       Impact factor: 5.758

Review 7.  Advances in targeted degradation of endogenous proteins.

Authors:  Sascha Röth; Luke J Fulcher; Gopal P Sapkota
Journal:  Cell Mol Life Sci       Date:  2019-04-27       Impact factor: 9.261

8.  Low affinity binding sites in an activating CRM mediate negative autoregulation of the Drosophila Hox gene Ultrabithorax.

Authors:  Rebecca K Delker; Vikram Ranade; Ryan Loker; Roumen Voutev; Richard S Mann
Journal:  PLoS Genet       Date:  2019-10-07       Impact factor: 5.917

Review 9.  Targeted Protein Degradation Tools: Overview and Future Perspectives.

Authors:  Yuri Prozzillo; Gaia Fattorini; Maria Virginia Santopietro; Luigi Suglia; Alessandra Ruggiero; Diego Ferreri; Giovanni Messina
Journal:  Biology (Basel)       Date:  2020-11-26

10.  Engineered kinases as a tool for phosphorylation of selected targets in vivo.

Authors:  Katarzyna Lepeta; Chantal Roubinet; Milena Bauer; M Alessandra Vigano; Gustavo Aguilar; Oguz Kanca; Amanda Ochoa-Espinosa; Dimitri Bieli; Clemens Cabernard; Emmanuel Caussinus; Markus Affolter
Journal:  J Cell Biol       Date:  2022-09-14       Impact factor: 8.077

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.